We track 74 stocks in the Pharmaceuticals & Biotechnology industry (part of Healthcare), each checked every evening for a base — a stretch where the price moves sideways in a range instead of trending.
As of the latest close, 50 are still building a base; 4 broke out of a base in the last five sessions; 13 broke out earlier and are still above the breakout level; 6 broke out but fell back below the breakout level; and 1 is not in a base we recognise.
The middle stock in this industry has a relative strength reading of 68 out of 99. That reading ranks each stock's price performance over the past year against every stock we track; half of this industry's 71 ranked stocks sit above 68 and half below. 35 stocks have a reading of 70 or higher.
58 of the 74 stocks we could measure (78%) closed above their 200-day average price — the average close over the last 200 trading sessions.